Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane ascorbate-dependent reductase cytochrome b561 (CYB561) is a multipass transmembrane enzyme that functions as an electron transporter, predominantly located in the membranes of secretory vesicles, such as chromaffin granules in neuroendocrine tissues[1][2][3]. This protein is involved in the transfer of electrons from cytosolic ascorbate (vitamin C) to intravesicular substrates, including iron (ferric chelates) and peptide-processing enzymes, thereby enabling enzymatic activities essential for neurotransmitter and peptide hormone biosynthesis (e.g., dopamine to norepinephrine conversion via dopamine-beta-hydroxylase)[1][2][3]. Structurally, it is composed of 273 amino acids with six transmembrane domains and two non-covalently bound heme groups that mediate electron transport[1][2][3]. CYB561 represents a distinct family of eukaryotic electron transfer enzymes and plays a key role in ascorbate recycling and iron absorption[3]. It is highly expressed in nervous and neuroendocrine tissues, such as the adrenal medulla and brain, but not in most peripheral organs[2]. No drugs are currently known to specifically target this protein, and no safety concerns or clinical biomarkers have been established for CYB561 as of current knowledge.
Substrate-mediated electron transfer from ascorbate to membrane-bound heme groups; Reduction of intravesicular ferric iron (Fe³⁺) to ferrous iron (Fe²⁺); Supply of reducing equivalents to enzymes (dopamine-beta-hydroxylase, peptide amidase)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane ascorbate-dependent reductase cytochrome b561 (CYB561).